Molecular Mechanism of Jinchan Oral Liquid in the Treatment of Children with Respiratory Syncytial Virus Pneumonia Based on Network Pharmacology and Molecular Docking Technology

OBJECTIVE: Exploration of the underlying molecular mechanism of Jinchan Oral Liquid (JOL) in treating children with the respiratory syncytial virus (RSV) pneumonia to provide new evidence for the clinical application. METHODS: The active components and target genes of JOL were screened by the TCMSP...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Li, Jiang, Yiguo, Lu, Jinmiao, Wang, Guangfei, Zhang, Xiaolan, He, Sumei, Wang, Cheng, Li, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416387/
https://www.ncbi.nlm.nih.gov/pubmed/34485521
http://dx.doi.org/10.1155/2021/6471400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416387/
https://www.ncbi.nlm.nih.gov/pubmed/34485521
http://dx.doi.org/10.1155/2021/6471400

Ejemplares similares